ERD

Sort by

European Partnerships

Show in overview

EU-Programme-Call

Show in overview

8 items found

Toggle all information

ISIDORe | Integrated Services for Infectious Disease Outbreak Research

01-02-2022

31-07-2025

Show more information

Organisation VACCINE FORMULATION INSTITUTE(CH)LTD

EHVA | European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

01-01-2016

31-12-2023

Show more information

Organisation VACCINE FORMULATION INSTITUTE(CH)LTD

TRANSVAC-DS | DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE

01-06-2020

28-02-2023

Show more information

Organisation VACCINE FORMULATION INSTITUTE(CH)LTD

TBVAC-HORIZON | Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity

01-04-2023

31-03-2027

Show more information

Organisation VACCINE FORMULATION INSTITUTE(CH)LTD

OptiMalVax | Optimizing a deployable high efficacy malaria vaccine

01-01-2017

31-12-2022

Show more information

Organisation VACCINE FORMULATION INSTITUTE(CH)LTD

OptiViVax | Optimising a High Efficacy Plasmodium vivax Malaria Vaccine

01-06-2023

31-05-2028

Show more information

Organisation VACCINE FORMULATION INSTITUTE(CH)LTD

UltiMalVax | A Vaccine Targeting Eradication of Malaria

01-05-2023

30-04-2027

Show more information

Organisation VACCINE FORMULATION INSTITUTE(CH)LTD

BAXERNA 2.0 | Immunopeptidomics-based Development of Next-Generation Bacterial mRNA Vaccines

01-07-2023

30-06-2028

Show more information

Organisation VACCINE FORMULATION INSTITUTE(CH)LTD

Projects overview

Selected filters:

ISIDORe | Integrated Services for Infectious Disease Outbreak Research

EHVA | European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

TRANSVAC-DS | DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE

TBVAC-HORIZON | Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity

OptiMalVax | Optimizing a deployable high efficacy malaria vaccine

OptiViVax | Optimising a High Efficacy Plasmodium vivax Malaria Vaccine

UltiMalVax | A Vaccine Targeting Eradication of Malaria

BAXERNA 2.0 | Immunopeptidomics-based Development of Next-Generation Bacterial mRNA Vaccines